IRIS Institutional Research Information System - OPENBS Open Archive UniBS

CAROSI, Giampiero
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.598
AS - Asia 10.297
EU - Europa 8.058
SA - Sud America 2.138
AF - Africa 173
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 22
Totale 40.310
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 19.339
CN - Cina 3.824
SG - Singapore 3.309
UA - Ucraina 2.838
BR - Brasile 1.847
HK - Hong Kong 1.377
DE - Germania 1.325
IT - Italia 1.167
FI - Finlandia 641
VN - Vietnam 527
GB - Regno Unito 480
TR - Turchia 449
IE - Irlanda 443
RU - Federazione Russa 436
IN - India 324
FR - Francia 198
SE - Svezia 159
PL - Polonia 133
CA - Canada 125
BD - Bangladesh 109
AR - Argentina 105
MX - Messico 89
IQ - Iraq 57
ZA - Sudafrica 57
EC - Ecuador 56
BE - Belgio 51
ID - Indonesia 42
AT - Austria 35
JP - Giappone 35
CO - Colombia 34
PK - Pakistan 34
NL - Olanda 32
ES - Italia 31
SA - Arabia Saudita 30
VE - Venezuela 30
UZ - Uzbekistan 29
AE - Emirati Arabi Uniti 22
AU - Australia 22
IR - Iran 22
MU - Mauritius 22
MA - Marocco 21
EU - Europa 20
LT - Lituania 19
PY - Paraguay 19
CZ - Repubblica Ceca 17
KE - Kenya 17
CL - Cile 14
EG - Egitto 14
IL - Israele 13
MY - Malesia 13
PE - Perù 13
UY - Uruguay 13
JO - Giordania 12
AZ - Azerbaigian 10
DZ - Algeria 8
HN - Honduras 8
JM - Giamaica 8
PT - Portogallo 8
BF - Burkina Faso 7
QA - Qatar 7
KZ - Kazakistan 6
OM - Oman 6
BO - Bolivia 5
CH - Svizzera 5
DO - Repubblica Dominicana 5
NI - Nicaragua 5
PA - Panama 5
RO - Romania 5
SN - Senegal 5
TN - Tunisia 5
BG - Bulgaria 4
BH - Bahrain 4
CR - Costa Rica 4
ET - Etiopia 4
GR - Grecia 4
HU - Ungheria 4
KG - Kirghizistan 4
KR - Corea 4
LB - Libano 4
NG - Nigeria 4
NP - Nepal 4
SK - Slovacchia (Repubblica Slovacca) 4
HR - Croazia 3
LA - Repubblica Popolare Democratica del Laos 3
LV - Lettonia 3
PH - Filippine 3
TT - Trinidad e Tobago 3
AL - Albania 2
AM - Armenia 2
BB - Barbados 2
BY - Bielorussia 2
GT - Guatemala 2
GY - Guiana 2
LK - Sri Lanka 2
MN - Mongolia 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
RS - Serbia 2
SI - Slovenia 2
TZ - Tanzania 2
Totale 40.287
Salva come PNG Salva come JPEG
Città #
Woodbridge 2.189
Fairfield 2.160
Jacksonville 2.080
Singapore 1.593
Hong Kong 1.375
Ashburn 1.366
Houston 1.199
Wilmington 1.143
Ann Arbor 1.023
Cambridge 951
Chandler 944
Nanjing 839
Seattle 810
Princeton 807
Beijing 591
Dublin 440
Istanbul 354
New York 354
Nanchang 290
Los Angeles 279
Buffalo 217
Des Moines 203
Shenyang 199
Helsinki 198
Ho Chi Minh City 195
Moscow 189
Hebei 175
Changsha 174
São Paulo 167
San Diego 147
Tianjin 140
Jiaxing 130
Jinan 130
Warsaw 129
Milan 120
Dearborn 119
The Dalles 108
Munich 104
Hanoi 97
Kunming 97
Shanghai 90
Hangzhou 81
Verona 77
San Francisco 68
Redondo Beach 64
Lancaster 63
Dallas 58
Kocaeli 56
Rio de Janeiro 55
Toronto 55
Zhengzhou 55
Brescia 53
Brussels 51
Chicago 51
Lanzhou 47
Guangzhou 44
Ningbo 41
Nuremberg 41
London 40
Mexico City 39
Boardman 38
Turku 38
Santa Clara 37
Belo Horizonte 36
Tokyo 33
Brooklyn 32
Taizhou 32
Curitiba 29
Washington 29
Leawood 28
Tashkent 28
Johannesburg 27
Montreal 27
Rome 27
Campinas 26
Brasília 25
Norwalk 25
Porto Alegre 25
Haikou 24
Pune 24
Denver 23
Guarulhos 21
Phoenix 21
Ribeirão Preto 20
Stockholm 20
Taiyuan 20
Atlanta 19
Augusta 19
Changchun 19
Salvador 19
Biên Hòa 18
Da Nang 18
Guayaquil 18
Quito 18
Charlotte 17
Haiphong 17
Sorocaba 17
Ardabil 16
Boston 16
Caxias do Sul 16
Totale 25.916
Salva come PNG Salva come JPEG
Nome #
Cos’è la Medicina Tropicale 246
Trends in methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections: effect of the MRSA "search and isolate" strategy in a hospital in Italy with hyperendemic MRSA 234
Cohort profile: Standardized management of antiretroviral therapy cohort (MASTER cohort) 204
The evolving burden of HIV infection compared with other chronic diseases in northern Italy 198
Evaluation of Liver Fibrosis: Concordance Analysis between Noninvasive Scores (APRI and FIB-4) Evolution and Predictors in a Cohort of HIV-Infected Patients without Hepatitis C and B Infection 190
Efficacy and tolerability of topical 1% cidofovir cream for the treatment of external anogenital warts in HIV-infected persons 190
Evolution of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy from 2000 to 2010. 189
Hepatitis C infection influence on immune recovery in HIV-positive patients on successful HAART: The role of genotype 3 185
Efficacy and safety of a switch to unboosted atazanavir in combination with nucleoside analogues in HIV-1-infected patients with virological suppression under antiretroviral therapy 176
Analysis of HIV-1 mutation patterns in patients failing antiretroviral therapy 167
Unboosted fosamprenavir is associated with low drug exposure in HIV-infected patients with mild-moderate liver impairment resulting from HCV-related cirrhosis 166
Malaria and anaemia in pregnant women in urban Zanzibar, Tanzania. 163
HIV-associated asymmetric lipodystrophy syndrome 163
Trigger-oriented HIV testing at Internal Medicine hospital Departments in Northern Italy: an observational study (Fo.C.S. Study) 160
Modifications of health resource-use in Italy after the introduction of highly active antiretroviral therapy (HAART) for human immunodeficiency virus (HIV) infection. Pharmaco-economic implications in a population-based setting 159
No evidence of relation between peripheral neuropathy and presence of hemochromatosis gene mutations in HIV-1-positive patients. 158
Use of efavirenz or atazanavir/ritonavir is associated with better clinical outcomes of HAART compared to other protease inhibitors: Routine evidence from the Italian MASTER Cohort 157
Genotype resistance profiles in patients failing an NNRTI-containing regimen, and modifications after stopping NNRTI therapy 156
Key Questions in antiretroviral therapy: Italian Consensus Workshop (2005) 155
Accidental and transfusion malaria in Italy 155
Decrease of HCVRNA after three days of daily interferon treatment is predictive of the virological response at one month 155
Prediction of early and confirmed virological response by genotypic inhibitory quotients for lopinavir in patients naive for lopinavir with limited exposure to previous protease inhibitors. 153
A randomized, controlled trial of triple antiviral therapy as initial treatment of chronic hepatitis C in HIV-infected patients. 152
Pilot dose-finding trial on interferon alpha in combination with ribavirin for the treatment of chronic hepatitis C in patients not responding to interferon alone 152
Influence of folate serum concentration on plasma homocysteine levels in HIV-positive patients exposed to protease inhibitors undergoing HAART. 151
HYALURONIC ACID AND LIVER STIFFNESS REDUCTION IN HIV-HEPATITIS-C (HCV) COINFECTED PATIENTS TREATED WITH A CCR5 INHIBITOR MARAVIROC (MVC) IN A RANDOMIZED CONTROLLED TRIAL (MAICOL STUDY-48-WEEK ANALYSIS) 151
Heterogeneity and penetration of HIV-1 non-subtype B viruses in an Italian province: public health implications. 148
A population-based database to study malignancies in HIV-infected patients in the Local Health Unit of Brescia (Northern Italy), period 1999-2009 147
Risk of chronic kidney disease among patients developing mild renal impairment during tenofovir-containing antiretroviral treatment 147
Long-Term Response in Patients Receiving Haart Including Nelfinavir: Experience from Two Italian Centers 146
Influence of viral chronic hepatitis co-infection on plasma drug concentrations and liver transaminase elevations upon therapy switch in HIV-positive patients. 146
Successful long-course after failure of short-course desensitization in a patient with severe hypersensitivity reaction to enfuvirtide 145
Bcl-2 expression is moderately correlated with long-term variability of CD4+ T-cell increase under successful highly active antiretroviral therapy 145
HIV susceptibility to amprenavir: phenotype-based versus rules-based interpretations 144
Adherence and plasma drug concentrations are predictors of confirmed virologic response after 24-week salvage highly active antiretroviral therapy. 144
Hepatitis B virus and HIV coinfection in low-income countries: unmet needs. 143
Incidence and risk factors for liver enzyme elevation during highly active antiretroviral therapy in HIV-HCV co-infected patients: results from the Italian EPOKA-MASTER Cohort. 142
HIV-1 genotype resistance pattern and evolution in patients failing nelfinavir containing regimens 141
Liver damage and kinetics of hepatitis C virus and human immunodeficiency virus replication during the early phases of combination antiretroviral treatment 141
Insulin resistance impairs rapid virologic response in HIV/hepatitis C virus coinfected patients on peginterferon-alfa-2a. 139
Liver fibrosis progression is related to CD4 cell depletion in patients coinfected with hepatitis C virus and Human Immunodeficiency Virus. 139
Modifications in SENV DNA detection and/or SENV subtype determination over a prospective follow-up in a cohort of HIV-positive patients: is this a moving target? 138
Recent increase in enterococci, viridans streptococci, Pseudomonas spp. and multiresistant strains among haematological patients, with a negative impact on outcome. Results of a 3-year surveillance study at a single institution. 138
Adherence to surgical site infection guidelines in Italian cardiac surgery units. 138
HIV-1 resistance to dideoxynucleoside reverse transcriptase inhibitors: genotypic-phenotypic correlations 136
Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction 135
STI epidemics in the Indian Ocean Region: can the phase be assessed? 134
Access to antiretroviral therapy and disease progression in HIV+ migrants in Brescia, Italy 134
Caratteri generali dei protozoi patogeni per l’uomo e delle infezioni protozoarie umane 134
Drug resistance mutations and newly recognized treatment-related substitutions in the HIV-1 protease gene: prevalence and associations with drug exposure and real or virtual phenotypic resistance to protease inhibitors in two clinical cohorts of antiretroviral experienced patients. 134
A Multicenter, double-blind trial of a high-dose caspofungin treatment regimen versus a standard caspofungin treatment regimen for adult patients with invasive candidiasis 134
High prevalence of radiological vertebral fractures in HIV-infected males 134
Access site-related infection in dialysis: the AStRID project: a multicenter prospective Italian study. 133
Interleukin-2 therapy in patients with HIV infection 133
Long-term CD4+ T-cell count evolution after switching from regimens including HIV nucleoside reverse transcriptase inhibitors (NRTI) plus protease inhibitors to regimens containing NRTI plus non-NRTI or only NRTI 132
Fatal disseminated toxoplasmosis during primary HIV infection. 131
Risk factors and clinical characteristics associated with hospitalization for community-acquired bacterial pneumonia in HIV-positive patients according to the presence of liver cirrhosis. 131
Immune correlates of virological response in HIV-positive patients after highly active antiretroviral therapy (HAART) 129
Malaria and HIV in adults: When the parasite runs into the virus 129
Filariasis in travelers presenting to the Geosentinel Surveillance Network 128
HIV-related liver disease: ARV drugs, coinfection, and other risk factors. 128
Treatment of cytomegalovirus esophagitis in patients with acquired immune deficiency syndrome: a randomized controlled study of Foscarnet versus Ganciclovir. 128
Recent acquired STD and the use of HAART in the Italian Cohort of Naive for Antiretrovirals (I.Co.N.A): analysis of the incidence of newly acquired hepatitis B infection and syphilis 128
Maternal characteristics during pregnancy and risk factors for positive HIV RNA at delivery: a single-cohort observational study (Brescia, Northern Italy). 128
Baggage Malaria in Italy: Cryptic Malaria explained? 127
VAGINAL COLONIZATION WITH CANDIDA SPP IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED WOMEN: A COHORT STUDY 127
The predictive role of NLR and PLR for solid non-AIDS defining cancer incidence in HIV-infected subjects: a MASTER cohort study 127
Dermatologic conditions of the ill returned traveler: an analysis from the GeoSentinel Surveillance Network 126
Characteristics of schistosomiasis in travelers reported to the GeoSentinel Surveillance Network 1997-2008 126
Towards HCV extinction with modern HCV treatment? “Yes we can!” 126
Real versus virtual phenotype to guide treatment in heavily pretreated patients: 48 week follow-up of the Genotipo-Fenotipo di Resistenza (GenPheRex) trial 125
Polymorphic immune restoration syndrome after effective HAART 125
Incidence of neutropenia and infections during combination treatment of chronic hepatitis C with pegylated interferon alfa-2a or alfa-2b plus ribavirin. 124
A randomized controlled trial to evaluate antiretroviral salvage therapy guided by rules-based or phenotype-driven HIV-1 genotypic drug-resistance interpretation with or without concentration-controlled intervention: the Resistance and Dosage Adapted Regimens (RADAR) study. 124
Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial 124
Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study. 123
Hodgkin disease developing in patients infected by human immunodeficiency virus results in clinical features and a prognosis similar to those in patients with human immunodeficiency virus-related non-Hodgkin lymphoma 123
CD4+ T cell evolution and predictors of its trend before and aftertenofovir/didanosine backbone in the presence of sustained undetectable HIV plasma viral load 123
Potential role of SEN virus on liver enzyme abnormalities in patients positive for hepatitis C virus with or without HIV infection. 122
Risk factors for myocardial infarction in HIV positive patients 122
Multicenter GeoSentinel analysis of rickettsial diseases in international travelers, 1996-2008 122
Mortality from HIV and TB coinfections is higher in Eastern Europe than in Western Europe and Argentina 121
Therapeutic immunization with HIV-1 Tat reduces immune activation and loss of regulatory T-cells and improves immune function in subjects on HAART 121
Viral tropism by geno2pheno as a tool for predicting CD4 decrease in HIV-1-infected naive patients with high CD4 counts 121
Hyperbilirubinemia during atazanavir treatment in 2,404 patients in the Italian atazanavir expanded access program and MASTER Cohorts 121
Seasonality, annual trends, and characteristics of dengue among ill returned travelers, 1997-2006 120
Clinical presentation and outcome of hepatocellular carcinoma in HIV infected patients. 120
Analisi estensiva di sequenza dei geni della trascrittasi inversa e della proteasi di HIV-1 in una coorte clinica di pazienti HIV positivi NAIVE per la terapia antiretrovirale. 120
Impact of unreported HIV-1 reverse transcriptase mutations on phenotypic resistance to nucleoside and non-nucleoside inhibitors. 120
Long-term benefit of genotypic-guided therapy and prevalence of multinucleoside resistance in an Italian group of antiretroviral multiexperienced patients 120
Italian consensus statement on paediatric HIV infection 120
Epidemiological features and case-management practices of imported malaria in northern Italy 119
Mortality for liver disease in patients with HIV infection: a cohort study 119
HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies 119
Clinical experiences with interferon as monotherapy or in combination with ribavirin in patients co-infected with HIV and HCV 118
The convenience of flow cytometry for HLA-B*5701 screening to prevent abacavir hypersensitivity reactions 118
Detection of drug resistance mutations at low plasma HIV-1 RNA load in a European multicentre cohort study 118
Supervised preventive therapy for latent tuberculosis infection in illegal immigrants in Italy 117
High prevalence of peripheral neuropathy in hepatitis C virus infected patients with symptomatic and asymptomatic cryoglobulinaemia 117
HIV infection among illegal migrants, Italy, 2004-2007 117
Totale 14.071
Salva come PNG Salva come JPEG
Categoria #
all - tutte 192.959
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 192.959
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.176 0 0 0 0 0 609 118 590 876 339 529 115
2021/20222.828 125 538 11 185 31 170 94 190 168 433 282 601
2022/20232.769 457 24 31 232 268 820 3 272 424 25 86 127
2023/20242.154 138 68 128 149 82 370 57 53 663 23 17 406
2024/20255.883 26 18 28 594 866 515 679 186 620 362 1.212 777
2025/20266.256 1.085 1.626 850 1.711 850 134 0 0 0 0 0 0
Totale 40.718